Cargando…

Recurrent ovarian cancer with multiple lymph nodes metastases successfully treated with lymphadenectomy as secondary cytoreductive surgery: A case report

INTRODUCTION: Occasionally, lymph node metastases represent the only component at the time of recurrence of ovarian cancer. Here we report the case of a 78-year-old Japanese female who underwent successful surgery for recurrent ovarian cancer with multiple lymph node metastases. PRESENTATION OF CASE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagano, Hiroaki, Muraoka, Mitsue, Takagi, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064423/ https://www.ncbi.nlm.nih.gov/pubmed/24880887 http://dx.doi.org/10.1016/j.ijscr.2014.04.017

Ejemplares similares

Patients with Advanced Ovarian Cancer Administered Oral Etoposide following Taxane as Maintenance Chemotherapy
por: Nagano, Hiroaki, et al.
Publicado: (2016)

Fetal Head Growth during Early to Mid-Gestation Associated with Weight Gain in Mothers with Hyperemesis Gravidarum: A Retrospective Cohort Study
por: Muraoka, Mitsue, et al.
Publicado: (2020)

Prognostic significance of lymph node metastasis and lymphadenectomy in early-stage ovarian carcinosarcoma
por: Wang, Wen-Peng, et al.
Publicado: (2018)

Prognostic Impact of Mesenteric Lymph Node Status on Digestive Resection Specimens During Cytoreductive Surgery for Ovarian Peritoneal Metastases
por: Channawi, Ali, et al.
Publicado: (2023)

Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
por: Certelli, Camilla, et al.
Publicado: (2023)

Transabdominal cardiophrenic lymph node dissection for cytoreductive surgery in advanced ovarian cancer
por: Yang, Hee Chul, et al.
Publicado: (2021)

Splenic and Peritoneal Metastases with Para-aortic and Virchow Lymph Node Metastases: Late Recurrence of Ovarian Cancer 30 Years after Initial Treatment
por: Takagi, Kosei, et al.
Publicado: (2021)

The current role of secondary cytoreductive surgery for recurrent ovarian cancer
por: de Bree, Eelco, et al.
Publicado: (2022)

Simplified Selection Criteria for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer
por: Son, Joo-Hyuk, et al.
Publicado: (2022)

Individualized Surgery: Gamma-Probe-Guided Lymphadenectomy in Patients with Clinically Enlarged Lymph Node Metastases from Melanomas
por: Kretschmer, Lutz, et al.
Publicado: (2013)

Hepatic Hilar Lymph Node Resection in Cytoreductive Surgery for Advanced Ovarian Cancer: A Necessity or Not?
por: Huang, Honglian, et al.
Publicado: (2021)

Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
por: Bogani, Giorgio, et al.
Publicado: (2018)

Impact of supradiaphragmatic lymphadenectomy on the survival of patients in stage IVB ovarian cancer with thoracic lymph node metastasis
por: Park, Soo Jin, et al.
Publicado: (2023)

The impact of lymphadenectomy on lymph node recurrence after performing various treatments for esophageal squamous cell carcinoma
por: Shigeno, Takashi, et al.
Publicado: (2022)

Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
por: Onda, T, et al.
Publicado: (2005)

Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
por: Zang, Rongyu, et al.
Publicado: (2019)

Extent of Lymphadenectomy in Esophageal Cancer: How Many Lymph Nodes Is Enough?
por: Herrera, Luis J.
Publicado: (2009)

Anatomic Aspects of Inguinal Lymph Nodes Applied to Lymphadenectomy in Penile Cancer
por: de Carvalho, João Paulo Martins, et al.
Publicado: (2011)

Right upper quadrant cytoreductive procedures and cardiophrenic lymph node resection in primary debulkig surgery for ovarian cancer
por: Casanova, Joao, et al.
Publicado: (2021)

Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review
por: Conte, Carmine, et al.
Publicado: (2021)

Prediction Models for Complete Resection in Secondary Cytoreductive Surgery of Patients With Recurrent Ovarian Cancer
por: Jiang, Caixia, et al.
Publicado: (2021)

Achieving adequate lymph node dissection in treating esophageal squamous cell carcinomas by radical lymphadenectomy: Beyond the scope of numbers of harvested lymph nodes
por: Lin, Zheng, et al.
Publicado: (2019)

Robotic assisted cytoreductive surgery, removal of a recurrent disease in the right pericaval lymph node in a patient with ovarian cancer with the robotic Xi platform
por: Shoraka, Massoud, et al.
Publicado: (2021)

Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy
por: Mabuchi, Seiji, et al.
Publicado: (2022)

Lymph Nodes Involvement and Lymphadenectomy in Thymic Tumors: Tentative Answers for Unsolved Questions
por: Brascia, Debora, et al.
Publicado: (2021)

Diagnostic biopsy of cutaneous melanoma, sentinel lymph node biopsy and indications for lymphadenectomy
por: Pavlidis, Efstathios T, et al.
Publicado: (2022)

Use of Porphysomes to detect primary tumour, lymph node metastases, intra-abdominal metastases and as a tool for image-guided lymphadenectomy: proof of concept in endometrial cancer
por: Philp, Lauren, et al.
Publicado: (2019)

Image-guided percutaneous targeting of lymph nodes: a novel approach for salvage pelvic lymphadenectomy in recurrent prostate cancer
por: Lemos, Gustavo Caserta, et al.
Publicado: (2017)

Ligation of lymph vessels for the treatment of recurrent inguinal lymphoceles following lymphadenectomy
por: Toyserkani, Navid Mohamadpour, et al.
Publicado: (2016)

Lymph Node Metastases Papillary Thyroid Carcinoma and their Importance in Recurrence of Disease
por: Maksimovic, Sinisa, et al.
Publicado: (2018)

SUN-310 Duodenal Wall Insulinoma with Recurrence as Lymph Node Metastases
por: Shenoy, Vikram, et al.
Publicado: (2019)

Fingerprinting Lymph Node Metastases
por: Symmans, W. Fraser, et al.
Publicado: (2008)

A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
por: Bogani, Giorgio, et al.
Publicado: (2018)

Tertiary cytoreduction in the setting of recurrent ovarian cancer (Review)
por: DOGAN, NASUH UTKU, et al.
Publicado: (2013)

Is D2 Lymphadenectomy Alone Suitable for Gastric Cancer With Bulky N2 and/or Para-Aortic Lymph Node Metastases After Preoperative Chemotherapy?
por: Xu, Wei, et al.
Publicado: (2021)

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
por: Jeong, Soo Young, et al.
Publicado: (2019)

The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us?
por: Coleman, Robert L.
Publicado: (2020)

Central lymph node metastasis is predictive of survival in advanced gastric cancer patients treated with D2 lymphadenectomy
por: Lu, Huiwen, et al.
Publicado: (2021)

The role of secondary full lymphadenectomy for patients with early-stage endometrial cancer and isolated tumor cells detected on sentinel lymph node biopsy
por: Mumford, B.S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_51e1fiqai05nj65ecve0diitdq